Phase 4 Glucocorticoid Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
Glucocorticoid-induced Osteoporosis
Amgen100 enrolled16 locationsNCT06588153
Recruiting
Phase 4
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050
Recruiting
Phase 4
Diesel Exhaust Induces Glucocorticoid Resistance
Exposure to PollutionGlucocorticoid Resistance
University of British Columbia30 enrolled1 locationNCT03615742
Recruiting
Phase 4
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
Immune ThrombocytopeniaChild, OnlyGlucocorticoids
Fujian Medical University Union Hospital608 enrolled1 locationNCT05522465
Not Yet Recruiting
Phase 4
Comparison of two tapering regimens in the management of glucocorticoid withdrawal - the PRED-STOP trial
glucocorticoid-responsive dermatological conditionspituitary-adrenal axis suppression
A/Prof W Inder - Investigator initiated120 enrolled1 locationACTRN12621000614897
Terminated
Phase 4
Novel approaches to manage glucocorticoid-induced diabetes in hospital inpatients
glucocorticoid-induced or -exacerbated diabetes
Alfred Hospital30 enrolled1 locationACTRN12615000333516